| scholarly article | Q13442814 |
| P2093 | author name string | David Elashoff | |
| Jerome A Zack | |||
| Saki Shimizu | |||
| Irvin S Y Chen | |||
| Dong Sung An | |||
| Gene-Errol Ringpis | |||
| Matthew D Marsden | |||
| Holly M Wilhalme | |||
| Ruth V Cortado | |||
| P2860 | cites work | Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs | Q37615893 |
| HIV latency | Q37974218 | ||
| Creating genetic resistance to HIV. | Q38044070 | ||
| Novel cell and gene therapies for HIV. | Q38048762 | ||
| HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain | Q39313963 | ||
| An unbiased genome-wide analysis of zinc-finger nuclease specificity | Q39493921 | ||
| HIV latency in the humanized BLT mouse | Q40321405 | ||
| Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5. | Q40847862 | ||
| The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. | Q43521980 | ||
| Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo | Q45869971 | ||
| Gene therapy. Intracellular immunization | Q45887946 | ||
| In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. | Q52050894 | ||
| Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. | Q53592113 | ||
| Time to hit HIV, early and hard. | Q55064177 | ||
| Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene | Q56591978 | ||
| Fighting HIV with stem cell therapy: one step closer to human trials? | Q85581135 | ||
| Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice | Q21133769 | ||
| Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion | Q24678540 | ||
| Hematopoietic-stem-cell-based gene therapy for HIV disease | Q27023434 | ||
| Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy | Q28253761 | ||
| Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation | Q28300338 | ||
| A TALE nuclease architecture for efficient genome editing | Q28301656 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene | Q29614892 | ||
| Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection | Q29614956 | ||
| Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation | Q29615068 | ||
| Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy | Q29615993 | ||
| Recovery of replication-competent HIV despite prolonged suppression of plasma viremia | Q29615995 | ||
| Enzymatic production of RNAi libraries from cDNAs. | Q33196418 | ||
| Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection | Q33283061 | ||
| Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5. | Q33465283 | ||
| A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model | Q33697336 | ||
| Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis. | Q33784940 | ||
| Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytes | Q34105986 | ||
| Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo | Q34124290 | ||
| Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. | Q34169244 | ||
| Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. | Q34220767 | ||
| High CCR5 density on central memory CD4+ T cells in acute HIV-1 infection is mostly associated with rapid disease progression | Q34490116 | ||
| Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition | Q34733983 | ||
| Stem cell-based anti-HIV gene therapy | Q34769333 | ||
| Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction | Q35122039 | ||
| Generation of HIV latency in humanized BLT mice | Q35666126 | ||
| Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates | Q35928777 | ||
| Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. | Q35943417 | ||
| The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes | Q36028490 | ||
| Stable gene transfer of CCR5 and CXCR4 siRNAs by sleeping beauty transposon system to confer HIV-1 resistance | Q36870325 | ||
| Genetic therapies against HIV. | Q37027170 | ||
| Specific transduction of HIV-susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunization. | Q37184391 | ||
| CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity | Q37271186 | ||
| P304 | page(s) | e227 | |
| P577 | publication date | 2015-02-17 | |
| P1433 | published in | Molecular Therapy. Nucleic acids | Q27724110 |
| P1476 | title | RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice | |
| P478 | volume | 4 |
| Q26767476 | Animal Models for HIV Cure Research |
| Q26781275 | Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure |
| Q38951248 | Gene transfer of two entry inhibitors protects CD4⁺ T cell from HIV-1 infection in humanized mice. |
| Q37593222 | Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice |
| Q36515124 | Hematopoietic stem cell transplantation for HIV cure |
| Q36515119 | In vivo platforms for analysis of HIV persistence and eradication |
| Q47110966 | Increasing the Clinical Potential and Applications of Anti-HIV Antibodies |
| Q49309806 | Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1. |
| Q40102925 | New approaches for the enhancement of chimeric antigen receptors for the treatment of HIV. |
| Q102144611 | Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo |
| Q38827119 | Stem cell-based therapies for HIV/AIDS. |
| Q39545359 | The Application of Humanized Mouse Models for the Study of Human Exclusive Viruses. |
| Q55078034 | The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer. |
| Q104617072 | Tracking HIV Rebound following Latency Reversal Using Barcoded HIV |
| Q28077662 | Using animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence research |
Search more.